Autor: "Atsuta, Yoshiko" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Impact on relapse of corticosteroid therapy after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
Autorzy:: Imahashi N; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya University, School of Medicine, Nagoya, Japan. />Inamoto Y
Seto A
Watanabe K
Nishiwaki S
Yanagisawa M
Shinba M
Yasuda T
Kuwatsuka Y
Atsuta Y
Kodera Y
Miyamura K; Pokaż więcej
Źródło:: Clinical transplantation [Clin Transplant] 2010 Nov-Dec; Vol. 24 (6), pp. 772-7.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Neoplasm Recurrence, Local*
Glucocorticoids/*therapeutic use
Graft vs Host Disease/*prevention & control
Leukemia, Myeloid, Acute/*surgery
Adolescent ; Adult ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Recurrence ; Risk Factors ; Survival Rate ; Transplantation, Autologous ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Mycophenolate mofetil use after unrelated hematopoietic stem cell transplantation for prophylaxis and treatment of graft-vs.-host disease in adult patients in Japan.
Autorzy:: Iida M; Department of HSCT Data Management and Biostatistics, Nagoya University School of Medicine, Nagoya, Japan; Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Aichi, Japan.
Fukuda T
Uchida N
Murata M
Aotsuka N
Minagawa K
Oohashi K
Fukushima K
Kondo T
Eto T
Miyamoto T
Morishima Y
Nagamura T
Atsuta Y
Suzuki R; Pokaż więcej
Źródło:: Clinical transplantation [Clin Transplant] 2014 Sep; Vol. 28 (9), pp. 980-9. Date of Electronic Publication: 2014 Jul 17.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Graft vs Host Disease/*therapy
Hematologic Diseases/*therapy
Immunosuppressive Agents/*therapeutic use
Mycophenolic Acid/*analogs & derivatives
Adolescent ; Adult ; Aged ; Female ; Follow-Up Studies ; Graft vs Host Disease/etiology ; Histocompatibility ; Humans ; Japan ; Male ; Middle Aged ; Mycophenolic Acid/therapeutic use ; Prognosis ; Retrospective Studies ; Tissue Donors ; Transplantation Conditioning ; Transplantation, Homologous ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Age influences post-graft-versus-host disease non-relapse mortality in adults with acute graft-versus-host disease of varying severity following allogeneic hematopoietic cell transplant.
Autorzy:: Nakane T; a Hematology, Graduate School of Medicine, Osaka City University , Osaka , Japan.; b GVHD working group of the Japan Society for Hematopoietic Cell Transplantation.
Fukuda T; b GVHD working group of the Japan Society for Hematopoietic Cell Transplantation.; c Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital , Tokyo , Japan.
Kanda J; b GVHD working group of the Japan Society for Hematopoietic Cell Transplantation.; d Division of Hematology, Saitama Medical Center, Jichi Medical University , Saitama , Japan.
Taniguchi S; e Department of Hematology , Toranomon Hospital , Tokyo , Japan.
Eto T; f Department of Hematology , Hamanomachi Hospital , Fukuoka , Japan.
Ohashi K; g Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital , Tokyo , Japan.
Nakamae H; a Hematology, Graduate School of Medicine, Osaka City University , Osaka , Japan.
Kurokawa M; h Department of Cell Therapy and Transplantation Medicine , University of Tokyo Hospital , Tokyo , Japan.
Mori T; b GVHD working group of the Japan Society for Hematopoietic Cell Transplantation.; i Division of Hematology, Department of Medicine , Keio University School of Medicine , Tokyo , Japan.
Morishima Y; b GVHD working group of the Japan Society for Hematopoietic Cell Transplantation.; j Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute , Nagoya , Japan.
Nagamura-Inoue T; k Department of Cell Processing and Transfusion , The Institute of Medical Science, The University of Tokyo , Japan.
Sakamaki H; g Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital , Tokyo , Japan.
Atsuta Y; l Department of Hematopoietic Stem Cell Transplantation Data Management and Biostatistics , Nagoya University School of Medicine , Nagoya , Japan.
Murata M; b GVHD working group of the Japan Society for Hematopoietic Cell Transplantation.; m Department of Hematology and Oncology , Nagoya University Graduate School of Medicine , Nagoya , Japan.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2015; Vol. 56 (8), pp. 2392-7. Date of Electronic Publication: 2015 Feb 09.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Graft vs Host Disease/*etiology
Graft vs Host Disease/*mortality
Hematopoietic Stem Cell Transplantation/*adverse effects
Adult ; Age Factors ; Aged ; Female ; Graft vs Host Disease/diagnosis ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Japan ; Male ; Middle Aged ; Mortality ; Outcome Assessment, Health Care ; Recurrence ; Risk Factors ; Severity of Illness Index ; Survival Analysis ; Transplantation Conditioning/adverse effects ; Transplantation Conditioning/methods ; Transplantation, Homologous ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy.
Autorzy:: Arai Y; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54, Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. .
Aoki K; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54, Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. .
Takeda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54, Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. .
Kondo T; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54, Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. .
Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan. .
Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan. .
Hashimoto H; Department of Hematology/Division of Stem Cell Transplantation, Kobe General Hospital/Institute of Biomedical Research and Innovation, Kobe, Japan. .
Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan. .
Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan. .
Kanda Y; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan. .
Kato C; Department of Hematology, Meitetsu Hospital, Nagoya, Japan. .
Kurokawa M; Department of Cell Therapy and Transplantation Medicine, the University of Tokyo Hospital, Tokyo, Japan. .
Iwato K; Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan. .
Onizuka M; Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan. .
Ichinohe T; Department of Hematology and Oncology, Hiroshima University Hospital, Hiroshima, Japan. .
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan. y-atsuta@jdchct.or.jp.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan. y-atsuta@jdchct.or.jp.
Takami A; Department of Internal Medicine Division of Hematology, Aichi Medical University, Nagakute, Japan. .; Pokaż więcej
Corporate Authors:: AML and MDS Working Group of Japan Society for Hematopoietic Cell Transplantation
Źródło:: Journal of hematology & oncology [J Hematol Oncol] 2015 Sep 04; Vol. 8, pp. 102. Date of Electronic Publication: 2015 Sep 04.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Bone Marrow Transplantation/*methods
Cyclophosphamide/*therapeutic use
Cytarabine/*therapeutic use
Myeloproliferative Disorders/*drug therapy
Peripheral Blood Stem Cell Transplantation/*methods
Adolescent ; Adult ; Cohort Studies ; Cyclophosphamide/pharmacology ; Cytarabine/pharmacology ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Tandem autologous versus autologous/allogeneic transplantation for multiple myeloma: propensity score analysis.
Autorzy:: Kawamura K; a Division of Hematology , Saitama Medical Center, Jichi Medical University , Saitama , Japan ;
Ikeda T; b Division of Hematology and Stem Cell Transplantation , Shizuoka Cancer Center , Shizuoka , Japan ;
Hagiwara S; c Division of Hematology, Internal Medicine , National Center for Global Health and Medicine , Tokyo , Japan ;
Mori T; d Department of Medicine, Division of Hematology , Keio University School of Medicine , Tokyo , Japan ;
Shinagawa A; e Department of Hematology , Hitachi General Hospital, Hitachi Ltd , Hitachi , Japan ;
Nishiwaki K; f Department of Internal Medicine, Division of Oncology and Hematology , Jikei University School of Medicine, Kashiwa Hospital , Kashiwa , Japan ;
Ohashi K; g Hematology Division , Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital , Tokyo , Japan ;
Kubonishi S; h Department of Hematology , National Hospital Organization Okayama Medical Center , Okayama , Japan ;
Fukuda T; i Division of Hematopoietic Stem Cell Transplantation , National Cancer Center Hospital , Tokyo , Japan ;
Ito T; j Second Department of Internal Medicine, Division of Hematology , Shinshu University School of Medicine , Matsumoto , Japan ;
Tomita N; k Department of Rheumatology/Hematology/Infectious Disease , Yokohama City University Hospital , Yokohama , Japan ;
Ichinohe T; l Department of Hematology and Oncology , Research Institute for Radiation Biology and Medicine, Hiroshima University , Hiroshima , Japan ;
Kato K; m Department of Hematology and Oncology , Children's Medical Center, Japanese Red Cross Nagoya First Hospital , Nagoya , Japan ;
Morishima Y; n Department of Epidemiology and Prevention , Aichi Cancer Center Research Institute , Nagoya , Japan ;
Atsuta Y; o Japanese Data Center for Hematopoietic Cell Transplantation , Nagoya, Japan ;; p Department of Healthcare Administration , Nagoya University Graduate School of Medicine , Nagoya , Japan ;
Sunami K; h Department of Hematology , National Hospital Organization Okayama Medical Center , Okayama , Japan ;
Kanda Y; a Division of Hematology , Saitama Medical Center, Jichi Medical University , Saitama , Japan ;; q Department of Medicine, Division of Hematology , Jichi Medical University , Shimotsuke , Japan.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2016 Sep; Vol. 57 (9), pp. 2077-83. Date of Electronic Publication: 2016 Mar 09.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/methods
Multiple Myeloma/*therapy
Adult ; Aged ; Biomarkers ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Multiple Myeloma/diagnosis ; Multiple Myeloma/mortality ; Neoplasm Staging ; Prognosis ; Propensity Score ; Retreatment ; Transplantation, Autologous ; Transplantation, Homologous ; Treatment Outcome ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission.
Autorzy:: Yanada M; Fujita Health University School of Medicine, Toyoake, Japan.
Kanda J; Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Ohtake S; Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Fukuda T; National Cancer Center Hospital, Tokyo, Japan.
Sakamaki H; Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Miyamura K; Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Miyawaki S; Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan.; Saiseikai Maebashi Hospital, Maebashi, Japan.
Uchida N; Toranomon Hospital, Tokyo, Japan.
Maeda T; Saitama International Medical Center, Saitama Medical University, Hidaka, Japan.
Nagamura-Inoue T; The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Asou N; Saitama International Medical Center, Saitama Medical University, Hidaka, Japan.; Kumamoto University School of Medicine, Kumamoto, Japan.
Morishima Y; Aichi Cancer Center Research Institute, Nagoya, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; Nagoya University Graduate School of Medicine, Nagoya, Japan.
Miyazaki Y; Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
Kimura F; National Defense Medical College, Tokorozawa, Japan.
Kobayashi Y; National Cancer Center Hospital, Tokyo, Japan.
Takami A; Aichi Medical University, Nagakute, Japan.
Naoe T; Nagoya University Graduate School of Medicine, Nagoya, Japan.; National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Kanda Y; Saitama Medical Center, Jichi Medical University, Saitama, Japan.; Pokaż więcej
Źródło:: European journal of haematology [Eur J Haematol] 2016 Sep; Vol. 97 (3), pp. 278-87. Date of Electronic Publication: 2016 Jan 20.
Typ publikacji:: Journal Article
MeSH Terms:: Bone Marrow Transplantation*/methods
Cord Blood Stem Cell Transplantation*/methods
Leukemia, Myeloid, Acute/*therapy
Adolescent ; Adult ; Clinical Decision-Making ; Clinical Trials, Phase III as Topic ; Female ; Humans ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/mortality ; Male ; Middle Aged ; Quality of Life ; Remission Induction ; Tissue Donors ; Transplantation, Homologous ; Treatment Outcome ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Autologous hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission: outcomes before and after the introduction of arsenic trioxide.
Autorzy:: Yanada M; a Fujita Health University School of Medicine , Toyoake , Japan.
Yano S; b Jikei University School of Medicine , Tokyo , Japan.
Kanamori H; c Kanagawa Cancer Center , Yokohama , Japan.
Gotoh M; d Tokyo Medical University , Tokyo , Japan.
Emi N; a Fujita Health University School of Medicine , Toyoake , Japan.
Watakabe K; e Tokyo Metropolitan Komagome Hospital , Tokyo , Japan.
Kurokawa M; f Graduate School of Medicine, The University of Tokyo , Tokyo , Japan.
Nishikawa A; g Wakayama Medical University , Wakayama , Japan.
Mori T; h Keio University School of Medicine , Tokyo , Japan.
Tomita N; i Yokohama City University Graduate School of Medicine , Yokohama , Japan.
Murata M; j Nagoya University Graduate School of Medicine , Nagoya , Japan.
Hashimoto H; k Kobe Medical Center Central Hospital/Foundation of Biomedical Research and Innovation , Kobe , Japan.
Henzan H; l Hamanomachi Hospital , Fukuoka , Japan.
Kanda Y; m Saitama Medical Center, Jichi Medical University , Saitama , Japan.
Sawa M; n Anjo Kosei Hospital , Anjo , Japan.
Kohno A; o JA Aichi Konan Kosei Hospital , Konan , Japan.
Atsuta Y; j Nagoya University Graduate School of Medicine , Nagoya , Japan.; p Japanese Data Center for Hematopoietic Cell Transplantation , Nagoya , Japan.
Ichinohe T; q Hiroshima University Hospital , Hiroshima , Japan.
Takami A; r Aichi Medical University School of Medicine , Nagakute , Japan.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2017 May; Vol. 58 (5), pp. 1061-1067. Date of Electronic Publication: 2016 Oct 05.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Leukemia, Promyelocytic, Acute/*therapy
Adolescent ; Adult ; Aged ; Antineoplastic Agents/therapeutic use ; Arsenic Trioxide ; Arsenicals/therapeutic use ; Combined Modality Therapy ; Female ; Humans ; Japan ; Leukemia, Promyelocytic, Acute/diagnosis ; Leukemia, Promyelocytic, Acute/mortality ; Male ; Middle Aged ; Oxides/therapeutic use ; Recurrence ; Remission Induction ; Transplantation Conditioning ; Transplantation, Autologous ; Treatment Outcome ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients.
Autorzy:: Yanada M; a Fujita Health University School of Medicine , Toyoake , Japan.
Mori J; b Jyoban Hospital Tokiwa-Group , Fukushima , Japan.
Aoki J; c Kanagawa Cancer Center , Yokohama , Japan.
Harada K; d Tokyo Metropolitan Komagome Hospital , Tokyo , Japan.
Mizuno S; e Aichi Medical University , Nagakute , Japan.
Uchida N; f Toranomon Hospital , Tokyo , Japan.
Kurosawa S; g National Cancer Center Hospital , Tokyo , Japan.
Toya T; d Tokyo Metropolitan Komagome Hospital , Tokyo , Japan.
Kanamori H; c Kanagawa Cancer Center , Yokohama , Japan.
Ozawa Y; h Japanese Red Cross Nagoya First Hospital , Nagoya , Japan.
Ogawa H; i Hyogo College of Medicine , Nishinomiya , Japan.
Henzan H; j Hamanomachi Hospital , Fukuoka , Japan.
Iwato K; k Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital , Hiroshima , Japan.
Sakura T; l Saiseikai Maebashi Hospital , Maebashi , Japan.
Ota S; m Sapporo Hokuyu Hospital , Sapporo , Japan.
Fukuda T; g National Cancer Center Hospital , Tokyo , Japan.
Ichinohe T; n Research Institute for Radiation Biology and Medicine , Hiroshima University , Hiroshima , Japan.
Atsuta Y; o Nagoya University Graduate School of Medicine , Nagoya , Japan.; p Japanese Data Center for Hematopoietic Cell Transplantation , Nagoya , Japan.
Yano S; q Jikei University School of Medicine , Tokyo , Japan.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2018 Mar; Vol. 59 (3), pp. 601-609. Date of Electronic Publication: 2017 Jul 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cytogenetic Analysis/*methods
Graft vs Host Disease/*mortality
Hematopoietic Stem Cell Transplantation/*classification
Hematopoietic Stem Cell Transplantation/*mortality
Leukemia, Myeloid, Acute/*therapy
Neoplasm Recurrence, Local/*mortality
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Graft vs Host Disease/etiology ; Graft vs Host Disease/pathology ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/etiology ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Retrospective Studies ; Risk Factors ; Survival Rate ; Transplantation Conditioning ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Which is more important for the selection of cord blood units for haematopoietic cell transplantation: the number of CD34-positive cells or total nucleated cells?
Autorzy:: Nakasone H; Division of Haematology, Saitama Medical Centre, Jichi Medical University, Saitama, Japan.
Tabuchi K; Department of Paediatrics and Data Centre, Tokyo Metropolitan Cancer and Infectious Diseases Centre, Komagome Hospital, Tokyo, Japan.
Uchida N; Department of Haematology, Toranomon Hospital, Tokyo, Japan.
Ohno Y; Department of Internal Medicine, Kitakyushu Municipal Medical Centre, Kitakyushu, Japan.
Matsuhashi Y; Department of Haematology, Kawasaki Medical School Hospital, Kurashiki, Japan.
Takahashi S; Division of Molecular Therapy, The Advanced Clinical Research Centre, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Onishi Y; Department of Haematology and Rheumatology, Tohoku University Hospital, Sendai, Japan.
Onizuka M; Department of Haematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
Kobayashi H; Department of Haematology, Nagano Red Cross Hospital, Nagano, Japan.
Fukuda T; Haematopoietic Stem Cell Transplantation Division, National Cancer Centre Hospital, Tokyo, Japan.
Ichinohe T; Department of Haematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Takanashi M; Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
Kato K; Department of Haematology and Oncology, Children's Medical Centre, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Atsuta Y; Japanese Data Centre for Haematopoietic Cell Transplantation, Nagoya, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yabe H; Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine, Isehara, Japan.
Kanda Y; Division of Haematology, Saitama Medical Centre, Jichi Medical University, Saitama, Japan.; Pokaż więcej
Źródło:: British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (1), pp. 166-169. Date of Electronic Publication: 2018 May 29.
Typ publikacji:: Comparative Study; Evaluation Study; Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Cord Blood Stem Cell Transplantation*/adverse effects
Antigens, CD34/*analysis
Cell Nucleus/*ultrastructure
Fetal Blood/*cytology
Child ; Graft Survival ; Graft vs Host Disease/epidemiology ; Graft vs Host Disease/etiology ; Humans ; Infant, Newborn ; Leukemia/therapy ; Lymphoma/therapy ; Middle Aged ; Neutrophils/cytology ; Retrospective Studies ; Risk

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning.
Autorzy:: Harada K; a Department of Hematology and Oncology , Tokai University School of Medicine , Isehara , Japan.
Yanada M; b Department of Hematology and Cell Therapy , Aichi Cancer Center , Nagoya , Japan.
Machida S; a Department of Hematology and Oncology , Tokai University School of Medicine , Isehara , Japan.
Kanamori H; c Department of Hematology , Kanagawa Cancer Center , Yokohama , Japan.
Onizuka M; a Department of Hematology and Oncology , Tokai University School of Medicine , Isehara , Japan.
Ozawa Y; d Department of Hematology , Japanese Red Cross Nagoya First Hospital , Nagoya , Japan.
Kobayashi H; e Department of Hematology , Nagano Red Cross Hospital , Nagano , Japan.
Sawa M; f Department of Hematology and Oncology , Anjo Kosei Hospital , Anjo , Japan.
Katayama Y; g Department of Hematology , Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital , Hiroshima , Japan.
Ohashi K; h Hematology Division , Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital , Tokyo , Japan.
Kanda J; i Department of Hematology and Oncology , Graduate School of Medicine, Kyoto University , Kyoto , Japan.
Ichinohe T; j Department of Hematology and Oncology , Research Institute for Radiation Biology and Medicine, Hiroshima University , Hiroshima , Japan.
Atsuta Y; k Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; l Department of Healthcare Administration , Nagoya University Graduate School of Medicine , Nagoya , Japan.
Yano S; m Division of Clinical Oncology and Hematology , The Jikei University School of Medicine , Tokyo , Japan.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2019 Jun; Vol. 60 (6), pp. 1493-1502. Date of Electronic Publication: 2018 Nov 20.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Chemoradiotherapy/*methods
Hematopoietic Stem Cell Transplantation/*methods
Leukemia, Myeloid, Acute/*therapy
Melphalan/*administration & dosage
Neoplasm Recurrence, Local/*epidemiology
Transplantation Conditioning/*methods
Whole-Body Irradiation/*methods
Adult ; Age Factors ; Aged ; Chemoradiotherapy/adverse effects ; Chemoradiotherapy/statistics & numerical data ; Disease-Free Survival ; Dose-Response Relationship, Drug ; Female ; Follow-Up Studies ; Graft vs Host Disease/etiology ; Graft vs Host Disease/prevention & control ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Japan/epidemiology ; Kaplan-Meier Estimate ; Leukemia, Myeloid, Acute/mortality ; Male ; Middle Aged ; Neoplasm Recurrence, Local/prevention & control ; Prognosis ; Registries/statistics & numerical data ; Retrospective Studies ; Transplantation Conditioning/adverse effects ; Transplantation, Homologous/adverse effects ; Transplantation, Homologous/methods ; Vidarabine/administration & dosage ; Vidarabine/analogs & derivatives ; Whole-Body Irradiation/adverse effects ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: The effect of melphalan dose and total body irradiation as reduced-intensity conditioning for acute lymphoblastic leukemia patients undergoing allogeneic stem cell transplantation.
Autorzy:: Harada K; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
Tachibana T; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
Ohashi K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
Kondo T; Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
Ishikawa J; Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.
Onizuka M; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
Imada K; Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan.
Fujisaki T; Department of Internal Medicine, Matsuyama Red Cross Hospital, Matsuyama, Japan.
Tanaka J; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
Fukuda T; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Tokyo, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kako S; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2019 Dec; Vol. 60 (14), pp. 3521-3528. Date of Electronic Publication: 2019 Jul 10.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hematopoietic Stem Cell Transplantation/*mortality
Melphalan/*therapeutic use
Neoplasm Recurrence, Local/*therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Transplantation Conditioning/*mortality
Whole-Body Irradiation/*mortality
Adolescent ; Adult ; Aged ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Myeloablative Agonists/therapeutic use ; Neoplasm Recurrence, Local/pathology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Prognosis ; Retrospective Studies ; Survival Rate ; Transplantation, Homologous ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Impact of CD56 Continuously Recognizable as Prognostic Value of Acute Promyelocytic Leukemia: Results of Multivariate Analyses in the Japan Adult Leukemia Study Group (JALSG)-APL204 Study and a Review of the Literature.
Autorzy:: Takeshita A; Transfusion and Cell Therapy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Higashiku 431-3192, Japan.
Asou N; International Medical Center, Saitama Medical University, 1397-1, Yamane, Hidaka 350-1298, Japan.
Atsuta Y; The Japanese Data Center for Hematopoietic Cell Transplantation, 1-1-20 Taikou-minami, Higashiku, Nagoya 461-0047, Japan.
Furumaki H; Transfusion and Cell Therapy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Higashiku 431-3192, Japan.
Sakura T; Hematology, Saiseikai Maebashi Hospital, 564-1, Kamishindenmachi, Maebashi 371-0821, Japan.
Ueda Y; Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki 710-8602, Japan.
Sawa M; Hematology and Oncology, Anjo Kosei Hospital, 28 Higashikurokute, Anjochou, Anjo 446-8602, Japan.
Dobashi N; Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishisinbashi, Minatoku, Tokyo 105-8461, Japan.
Taniguchi Y; Hematology and Rheumatology, Kindai University Faculty of Medicine, 377-2 Ohnohigashi, Ohsakasayama 589-8511, Japan.
Suzuki R; Hematology and Oncology, Tokai University School of Medicine, 143 Shimokasuya, Isahara 259-1193, Japan.
Nakagawa M; Hematology and Rheumatology, Nihon University School of Medicine, 30-1 Ohyaguchikamichou, Itabashiku, Tokyo 173-8610, Japan.
Tamaki S; Hematology, Japanese Red Cross Ise Hospital, 1-471-2 Funae, Ise 516-8512, Japan.
Hagihara M; Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawaku, Yokohama 236-0004, Japan.
Fujimaki K; Hematology, Fujisawa City Hospital, 2-6-1 Fujisawa, Fujisawa 251-8550, Japan.
Minamiguchi H; Hematology, Shiga University of Medical Science, Seta-Tsukinowa, Otsu 520-2192, Japan.
Fujita H; Hematology, Saiseikai Yokohama Nanbu Hospital, 3-2-10 Kounandai, Kounanku, Yokohama 234-0054, Japan.
Yanada M; Hematology and Cell Therapy, Aichi Cancer Center, 1-1 Kanokoden, Chikusaku, Nagoya 464-8681, Japan.
Maeda Y; Hematology, Oncology and Respiratory Medicine, Okayama University Medical School, 2-5-1 Shikatachou, Kitaku, Okayama 700-8558, Japan.
Usui N; Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishisinbashi, Minatoku, Tokyo 105-8461, Japan.
Kobayashi Y; National Cancer Center Hospital, 5-1-1 Tsukiji, Chuouku, Tokyo 104-0045, Japan.
Kiyoi H; Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumaichou, Showaku, Nagoya 466-8550, Japan.
Ohtake S; Kanazawa University, Kakumamachi, Kanazawa 920-1192, Japan.
Matsumura I; Hematology and Rheumatology, Kindai University Faculty of Medicine, 377-2 Ohnohigashi, Ohsakasayama 589-8511, Japan.
Naoe T; National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Nakaku, Nagoya 460-0001, Japan.
Miyazaki Y; Hematology, Atomic Bomb Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.
Group TJALS; JALSG office, 3-6-35 Nishiki, Nakaku, Nagoya 460-0003, Japan.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2020 Jun 01; Vol. 12 (6). Date of Electronic Publication: 2020 Jun 01.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Personalized prediction of overall survival in patients with AML in non-complete remission undergoing allo-HCT.
Autorzy:: Hirabayashi S; Department of Hematology and Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Uozumi R; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kondo T; Department of Hematology and Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Arai Y; Department of Hematology and Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Kyoto, Japan.
Kawata T; Department of Hematology and Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
Marumo A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Ikegame K; Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
Tanaka M; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
Wake A; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital Kajigaya, Kawasaki, Japan.
Kanda J; Department of Hematology and Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kimura T; Preparation Department, Japanese Red Cross Kinki Block Blood Center, Osaka, Japan.
Tabuchi K; Department of Pediatrics, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan.; Tokyo Cancer Registry, Bureau of Social Welfare and Public Health, Tokyo Metropolitan Government, Tokyo, Japan.
Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yanada M; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
Yano S; Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2021 Jul; Vol. 10 (13), pp. 4250-4268. Date of Electronic Publication: 2021 Jun 16.
Typ publikacji:: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms:: Nomograms*
Bone Marrow Transplantation/*mortality
Cord Blood Stem Cell Transplantation/*mortality
Hematopoietic Stem Cell Transplantation/*mortality
Leukemia, Myeloid, Acute/*mortality
Adult ; Age Factors ; Bone Marrow Transplantation/methods ; Busulfan ; Cord Blood Stem Cell Transplantation/methods ; Cyclophosphamide ; Cytarabine ; Female ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Immunosuppressive Agents ; Kaplan-Meier Estimate ; Karnofsky Performance Status ; Leukemia, Myeloid, Acute/drug therapy ; Leukemia, Myeloid, Acute/therapy ; Male ; Melphalan ; Middle Aged ; Peripheral Blood Stem Cell Transplantation/mortality ; Retrospective Studies ; Transplantation Conditioning/methods ; Transplantation Conditioning/mortality ; Transplantation, Homologous ; Vidarabine/analogs & derivatives ; Whole-Body Irradiation

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia with high hyperdiploidy: a retrospective nationwide study.
Autorzy:: Kurosawa S; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Kaito S; Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan.
Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Mori T; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Hasegawa Y; Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Takada S; Leukemia Research Center, Saiseikai Maebashi Hospital, Gunma, Japan.
Sakaida E; Department of Hematology, Chiba University Hospital, Chiba, Japan.
Tanaka M; Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan.
Ikegame K; Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.
Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Aichi, Japan.; Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Aichi, Japan.
Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2021 Oct; Vol. 62 (10), pp. 2514-2520. Date of Electronic Publication: 2021 May 12.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/epidemiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Adult ; B-Lymphocytes ; Humans ; Prognosis ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia.
Autorzy:: Fujioka Y; Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan.; Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Chiba 277-8577, Japan.
Sugiyama D; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Matsumura I; Department of Hematology and Oncology, Kinki University Hospital, Osaka 589-8511, Japan.
Minami Y; Department of Hematology, National Cancer Center Hospital East, Kashiwa 277-0882, Japan.
Miura M; Department of Pharmacy, Akita University Hospital, Akita 010-8543, Japan.
Atsuta Y; The Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya 461-0047, Japan.
Ohtake S; Kanazawa University, Kanazawa 920-1192, Japan.
Kiyoi H; Department of Hematology and Oncology, Nagoya University, Nagoya 464-8601, Japan.
Miyazaki Y; Department of Hematology, Nagasaki University, Nagasaki 852-8521, Japan.
Nishikawa H; Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Chiba 277-8577, Japan.; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.; Division of Cancer Immunology, Research Institute, National Cancer Center, Tokyo 104-0045, Japan.
Takahashi N; Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2021 Nov 24; Vol. 13 (23). Date of Electronic Publication: 2021 Nov 24.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Difference in outcomes following allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndromes.
Autorzy:: Yanada M; Aichi Cancer Center, Nagoya, Japan.
Mizuno S; Aichi Medical University, Nagakute, Japan.
Yamasaki S; Kyusyu University Beppu Hospital, Beppu, Japan.
Harada K; Tokai University School of Medicine, Isehara, Japan.
Konuma T; The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Tamaki H; Hyogo College of Medicine, Nishinomiya, Japan.
Shingai N; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Uchida N; Toranomon Hospital, Tokyo, Japan.
Ozawa Y; Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Tanaka M; Kanagawa Cancer Center, Yokohama, Japan.
Onizuka M; Tokai University School of Medicine, Isehara, Japan.
Sawa M; Anjo Kosei Hospital, Anjo, Japan.
Nakamae H; Graduate School of Medicine, Osaka City University, Osaka, Japan.
Shiratori S; Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Matsuoka KI; Okayama University Hospital, Okayama, Japan.
Eto T; Hamanomachi Hospital, Fukuoka, Japan.
Kawakita T; National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
Maruyama Y; Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Ichinohe T; Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Kanda Y; Jichi Medical University, Shimotsuke, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; Nagoya University Graduate School of Medicine, Nagoya, Japan.
Aoki J; National Cancer Center Hospital, Tokyo, Japan.
Yano S; The Jikei University School of Medicine, Tokyo, Japan.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2021 Dec; Vol. 62 (14), pp. 3411-3419. Date of Electronic Publication: 2021 Aug 04.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/adverse effects
Leukemia, Myeloid, Acute/*therapy
Myelodysplastic Syndromes/*therapy
Humans ; Leukemia, Myeloid, Acute/diagnosis ; Myelodysplastic Syndromes/complications ; Myelodysplastic Syndromes/diagnosis ; Recurrence ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Stem cell transplantation for pediatric patients with adrenoleukodystrophy: A nationwide retrospective analysis in Japan.
Autorzy:: Kato K; Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Yabe H; Division of Stem Cell Transplantation, Department of Innovative Medicine, Tokai University School of Medicine, Isehara, Japan.
Shimozawa N; Division of Genomics Research, Life Science Research Center, Gifu University, Gifu, Japan.
Adachi S; Human Health Sciences, Kyoto University, Kyoto, Japan.
Kurokawa M; Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Hashii Y; Department of Pediatrics, Osaka International Cancer Institute, Osaka, Japan.
Sato A; Department of Hematology and Oncology, Miyagi Children's Hospital, Sendai, Japan.
Yoshida N; Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Kaga M; Department of Developmental Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Onodera O; Department of Neurology, Clinical Neuroscience Branch, Brain Research Institute, Niigata University, Niigata, Japan.
Kato S; Division of Stem Cell Transplantation, Department of Innovative Medicine, Tokai University School of Medicine, Isehara, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
Morio T; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan.; Pokaż więcej
Źródło:: Pediatric transplantation [Pediatr Transplant] 2022 Feb; Vol. 26 (1), pp. e14125. Date of Electronic Publication: 2021 Oct 18.
Typ publikacji:: Journal Article
MeSH Terms:: Adrenoleukodystrophy/*therapy
Stem Cell Transplantation/*methods
Transplantation Conditioning/*methods
Adolescent ; Adrenoleukodystrophy/mortality ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Japan/epidemiology ; Male ; Retrospective Studies ; Survival Analysis ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis.
Autorzy:: Suzuki K; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Kashiwa, Japan.; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Kashiwa, Japan.
Mizuno S; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
Shimazu Y; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Fuchida SI; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
Hagiwara S; Division of Hematology, Tsukuba University Hospital Mito Clinical Education and Training Center, Tsukuba, Japan.
Itagaki M; Department of Hematology, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan.
Nishiwaki K; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Kashiwa, Japan.; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Kashiwa, Japan.
Hangaishi A; Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan.
Karasuno T; Division of Hematology, Rinku General Medical Center, Izumisano, Japan.
Kikuchi T; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Shimizu M; Department of Hematology and Oncology, Hitachi, Ltd. Hitachi General Hospital, Hitachi, Japan.
Nishikawa A; Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
Kobayashi T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
Sunami K; Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
Uchiyama H; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
Maruyama Y; Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan.
Kanda Y; Division of Hematology, Jichi Medical University, Shimotsuke, Japan.
Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Aichi, Japan.; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Aichi, Japan.
Yano S; Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Kashiwa, Japan.
Kawamura K; Division of Clinical Laboratory Medicine, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Tottori, Japan.; Pokaż więcej
Corporate Authors:: Working Group of the Japan Society
for Transplantation and Cellular Therapy
Źródło:: European journal of haematology [Eur J Haematol] 2023 Apr; Vol. 110 (4), pp. 444-454. Date of Electronic Publication: 2023 Jan 17.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Multiple Myeloma*
Humans ; Aged ; Retrospective Studies ; Transplantation, Autologous ; Stem Cell Transplantation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Impact of anti-thymocyte globulin on survival outcomes in female-to-male allogeneic hematopoietic stem cell transplantation.
Autorzy:: Tamaki M; Division of Hematology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan. .
Akahoshi Y; Division of Hematology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Ashizawa M; Division of Hematology, Jichi Medical University, Shimotsuke, Japan.
Misaki Y; Division of Hematology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan.
Koi S; Hematology Division, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan.
Kim SW; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
Ozawa Y; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.
Fujiwara SI; Division of Hematology, Jichi Medical University, Shimotsuke, Japan.
Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan.
Matsuoka KI; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
Katayama Y; Department of Hematology, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima, Japan.
Onizuka M; Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan.
Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan.; Division of Hematology, Jichi Medical University, Shimotsuke, Japan.
Fukuda T; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.; Department of Registry Science for Transplantation and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
Yakushijin K; Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan.
Nakasone H; Division of Hematology, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan. .; Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, 329-0498, Japan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 May 03; Vol. 13 (1), pp. 7166. Date of Electronic Publication: 2023 May 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/methods
Graft vs Host Disease*/etiology
Humans ; Male ; Female ; Antilymphocyte Serum/therapeutic use ; Retrospective Studies ; Tissue Donors ; Transplantation Conditioning/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Atsuta, Yoshiko"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język